EFX vs PTCT · P/E 54, rev $5.68B vs rev $806.8M
Equifax Inc (EFX) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the EFX and PTCT stock pages for the full models.
Not investment advice.